Two histologically distinct subtypes of rhabdomyosarcomas (RMS), embryonal and alveolar, are different in many aspects, such as age distribution, primary site, and clinical outcome. We analyzed a group of 30 patients with RMS. The aim was to broaden the spectrum of diagnostic tools in evaluating the primary tumors, their recurrences and/or metastases, and to extend the diagnostic boundary to bone marrow and purged peripheral progenitor blood cell samples. We have performed the RT-PCR assay to analyze RMS for the presence of expression of MyoD1 gene and for the presence of chimeric transcripts PAX3/FKHR or PAX7/FKHR. MyoD1 gene expression was found in all 30 patients in samples from primary tumors. The chimeric transcripts PAX/FKHR were identified in 13 of 15 patients with alveolar RMS. Furthermore, the fusion transcript PAX7/FKHR was identified in 2 of 15 patients with RMS classified as embryonal by histology. Bone marrow samples (12) and peripheral blood progenitor cell specimens (13) in ten patients were examined by RT-PCR. We were able to identify 7 patients with bone marrow involvement and/or with contamination of peripheral blood progenitor cells by the tumor cells. We demonstrate that employing molecular diagnostics has an impact on staging, therapy monitoring and recognition of malignant cells at the tumor resection margins.

Department of Pathology and Molecular Medicine 2nd Medical School Charles University and Faculty Hospital in Motol Prague Czech Republic

Zobrazit více v PubMed

Bone Marrow Transplant. 1999 Sep;24(5):527-33 PubMed

Cancer. 1996 Sep 15;78(6):1320-7 PubMed

J Mol Diagn. 1999 Nov;1(1):23-31 PubMed

Cancer. 1984 Jan 15;53(2):368-73 PubMed

Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8047-51 PubMed

Mod Pathol. 2001 May;14(5):506-14 PubMed

Cancer Genet Cytogenet. 1986 Jan 15;19(3-4):361-2 PubMed

J Clin Oncol. 1997 May;15(5):1831-6 PubMed

J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):483-91 PubMed

Am J Surg Pathol. 1989 Feb;13(2):120-32 PubMed

Med Pediatr Oncol. 1993;21(2):83-7 PubMed

Am J Pathol. 1995 Dec;147(6):1799-810 PubMed

Cancer. 1995 Sep 15;76(6):1073-85 PubMed

Genes Chromosomes Cancer. 1989 Sep;1(1):23-35 PubMed

Development. 1994 Mar;120(3):603-12 PubMed

Cancer. 1991 Jun 15;67(12):3072-80 PubMed

Cytogenet Cell Genet. 1987;45(3-4):148-55 PubMed

Am J Pathol. 1998 Feb;152(2):577-83 PubMed

Genes Chromosomes Cancer. 1991 Nov;3(6):480-2 PubMed

Am J Pathol. 2000 Feb;156(2):399-408 PubMed

Cancer Genet Cytogenet. 1999 Jan 15;108(2):127-32 PubMed

Br J Cancer. 1987 Sep;56(3):379-80 PubMed

Cancer Res. 1999 Apr 1;59(7 Suppl):1711s-1715s PubMed

Am J Surg Pathol. 2001 Sep;25(9):1150-7 PubMed

Mod Pathol. 2000 Sep;13(9):988-93 PubMed

Med Pediatr Oncol. 1999 Dec;33(6):530-5 PubMed

Am J Surg Pathol. 2001 Jul;25(7):856-64 PubMed

Med Pediatr Oncol. 1998 Mar;30(3):156-9 PubMed

Science. 1991 Feb 15;251(4995):761-6 PubMed

Cancer Res. 1994 Jun 1;54(11):2869-72 PubMed

Br J Haematol. 2000 Jun;109(3):622-8 PubMed

Genes Chromosomes Cancer. 1999 Dec;26(4):275-85 PubMed

Diagn Mol Pathol. 2000 Mar;9(1):9-13 PubMed

Am J Pathol. 1998 Apr;152(4):1071-9 PubMed

Pathol Res Pract. 1989 Aug;185(2):207-13 PubMed

Semin Diagn Pathol. 1994 Feb;11(1):26-38 PubMed

Mod Pathol. 1997 Dec;10(12):1175-87 PubMed

Arch Pathol Lab Med. 2003 Oct;127(10):1290-7 PubMed

Clin Cancer Res. 1998 Feb;4(2):343-8 PubMed

Mod Pathol. 1994 Jan;7(1):69-75 PubMed

Am J Pathol. 1995 Mar;146(3):626-34 PubMed

Cell. 1987 Dec 24;51(6):987-1000 PubMed

Haematologica. 1999 Jun;84 Suppl EHA-4:107-9 PubMed

N Engl J Med. 1991 Feb 14;324(7):436-42 PubMed

Cancer Res. 2004 Aug 15;64(16):5539-45 PubMed

Leukemia. 2001 Jul;15(7):1060-5 PubMed

Hum Pathol. 1999 Dec;30(12):1519-22 PubMed

Cancer Res. 1994 Dec 15;54(24):6306-10 PubMed

Cell Growth Differ. 1996 Mar;7(3):405-12 PubMed

Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma